Okay, let's tackle this question. The user is asking about an orally active direct Xa inhibitor. First, I need to recall which anticoagulants are direct Xa inhibitors. The direct Xa inhibitors include rivaroxaban, apixaban, edoxaban, and betrixaban. These are all oral drugs, unlike older agents like warfarin or heparin.

Wait, the question is about which one is orally active. So the correct answer should be one of these four. Let me check the options. The user didn't provide the options, but maybe the correct answer is rivaroxaban? That's a common one. But I need to make sure. Let's think about the options. The options might include other anticoagulants like enoxaparin, which is a low molecular weight heparin and given by injection, not oral. Or maybe dabigatran, which is a direct thrombin inhibitor, not Xa. So if the options include dabigatran, that's incorrect.

The core concept here is the classification of anticoagulants. Direct Xa inhibitors are a class of anticoagulants that inhibit factor Xa directly, which is part of the coagulation cascade. They are used for conditions like deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation. The key point is that they are taken orally, unlike unfractionated heparin or LMWHs which are administered parenterally.

So the correct answer would be one of the oral Xa inhibitors. The incorrect options would include other anticoagulants that are not Xa inhibitors or not oral. For example, if an option is warfarin, that's a vitamin K antagonist, not a direct Xa inhibitor. Or if an option is a direct thrombin inhibitor like dabigatran, that's a different class.

The clinical pearl here is to remember the "NOACs" (Novel Oral Anticoagulants), which include the direct Xa inhibitors and direct thrombin inhibitors. The Xa inhibitors are usually names ending with -xab, like rivaroxaban, apixaban, edoxaban. The thrombin inhibitors end with -n, like dabigatran.

So, putting it all together, the correct answer is likely one of these Xa inhibitors. The explanation should clarify why each option is right or wrong based on their mechanism and route of administration. The high-yield fact is to distinguish between direct Xa inhibitors and other anticoagulants, especially thrombin inhibitors and VKAs.

**Core Concept**
Direct factor Xa inhibitors are anticoagulants that block the activated clotting factor Xa, preventing thrombin generation. Orally active agents in this class include rivaroxaban, apixaban, edoxaban, and betrixaban, which are used for venous thromboembolism and stroke prevention in atrial fibrillation.

**Why the Correct Answer is Right**
Rivaroxaban (a direct Xa inhibitor) is orally bioavailable and acts directly on factor Xa in the coagulation cascade. It bypasses the need for parenteral administration, unlike heparin or enoxaparin. Its mechanism involves competitive inhibition of Xa’s active site, reducing thrombin formation and clot propagation

✓ Correct Answer: A. Rivaroxaban